(HealthDay)—Lisdexamfetamine dimesylate (LDX) is associated with early improvement in efficacy measures in adults with binge-eating disorder (BED), according to research published in the August issue of the International ...
(HealthDay)—The reconstruction method may affect postoperative bone mineral density (BMD) loss in gastric cancer, according to a study published online July 31 in the Journal of Gastroenterology and Hepatology.
(HealthDay)—Participants with grass pollen-induced allergic rhinitis undergo epigenetic changes within three hours of exposure to grass pollen, according to a study published online July 29 in Allergy.
(HealthDay)—About 15 percent of octogenarians and nonagenarians with stage II/III rectal adenocarcinoma do not receive treatment, according to a study published online July 31 in Cancer.
(HealthDay)—The glucagon receptor blocker REGN1193, a fully human monoclonal antibody, seems safe and tolerable enough for further development, according to a study published online July 28 in Diabetes, Obesity and Metabolism.
(HealthDay)—Regular use of fluticasone furoate (FF), either alone or in combination with vilanterol (VI), appears to reduce the rate of forced expiratory volume in one second (FEV1) decline in patients with moderate chronic ...
(HealthDay) —Mavyret (glecaprevir and pibrentasvir) has been approved by the U.S. Food and Drug Administration to treat adults with certain types of chronic hepatitis C virus (HCV).
(HealthDay)—Older teens are more likely to do risky things while driving and have a higher rate of crashes and near misses than their younger classmates, a new survey finds.
Heart failure refers to a condition in which heart muscle becomes weakened over time, making it increasingly difficult for the heart to pump blood through the body like it should.
Platelets, the cells in blood that enable clotting, are highly reliant on their ability to metabolize glucose, according to a new study by researchers at the University of Iowa.